Addex Therapeutics's total assets for Q3 2025 were CHF7.33M, a decrease of -13.82% from the previous quarter. ADXN total liabilities were CHF1.37M for the fiscal quarter, a 6.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.